Prevalence of Left Ventricular Diastolic Dysfunction in a General Population
Authors:
- Tatiana KuznetsovaTKTatiana Kuznetsova
- Lieven HerbotsLHLieven Herbots
- Begoña LópEzBLBegoña LópEz
- Yu JinYJYu Jin
- Tom RichartTRTom Richart
- Lutgarde ThijsLTLutgarde Thijs
- Arantxa GonzálEzAGArantxa GonzálEz
- Marie-Christine HerregodsMHMarie-Christine Herregods
- Robert H. FagardRFRobert H. Fagard
- Javier DíeZJDJavier DíeZ
- Jan A. StaessenJSJan A. Staessen
- 1 March 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 2 (2) , 105-112
Abstract
Background— Because the process of myocardial remodelling starts before the onset of symptoms, recent heart failure (HF) guidelines place special emphasis on the detection of subclinical left ventricular (LV) systolic and diastolic dysfunction and the timely identification of risk factors for HF. Our goal was to describe the prevalence and determinants (risk factors) of LV diastolic dysfunction in a general population and to compare the amino terminal probrain natriuretic peptide level across groups with and without diastolic dysfunction. Methods and Results— In a randomly recruited population sample (n=539; 50.5% women; mean age, 52.5 years), we measured early and late diastolic peak velocities of mitral inflow (E and A), pulmonary vein flow by pulsed-wave Doppler, and the mitral annular velocities (Ea and Aa) at 4 sites by tissue Doppler imaging. A healthy subsample of 239 subjects (mean age, 43.7 years) provided age-specific cutoff limits for normal E/A and E/Ea ratios and the differences in duration between the mitral A and the reverse pulmonary vein flows during atrial systole (ΔAd−ARd). The number of subjects in diastolic dysfunction groups 1 (impaired relaxation), 2 (elevated LV end-diastolic filling pressure), and 3 (elevated E/Ea and abnormally low E/A) were 53 (9.8%), 76 (14.1%), and 18 (3.4%), respectively. We used Δ(AdP =0.015) and group 2 (209 versus 275 pmol/L; P =0.0003) but not group 3 (209 versus 224 pmol/L; P =0.65) had a significantly higher adjusted NT-probrain natriuretic peptide. Higher age, body mass index, heart rate, systolic blood pressure, serum insulin, and creatinine were significantly associated with a higher risk of LV diastolic dysfunction. Conclusions— The overall prevalence of LV diastolic dysfunction in a random sample of a general population, as estimated from echocardiographic measurements, was as high as 27.3%.Keywords
This publication has 20 references indexed in Scilit:
- Effects of genetic variation in adducin on left ventricular diastolic function as assessed by tissue Doppler imaging in a Flemish populationJournal Of Hypertension, 2008
- How to diagnose diastolic heart failure a consensus statementEuropean Heart Journal, 2007
- Angiotensin-Converting Enzyme I/D and α-Adducin Gly460Trp PolymorphismsHypertension, 2007
- How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of CardiologyEuropean Heart Journal, 2007
- Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic surveyHeart, 2006
- Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General PopulationHypertension, 2005
- The natriuretic peptides in cardiovascular medicineCurrent Problems in Cardiology, 2004
- American Society of Echocardiography recommendations for use of echocardiography in clinical trialsJournal of the American Society of Echocardiography, 2004
- Mitral flow derived Doppler indices of left ventricular diastolic function in a general population. The Tromsø studyEuropean Heart Journal, 2000
- Assessment of left ventricular end-diastolic pressure by Doppler echocardiography: Contribution of duration of pulmonary venous versus mitral flow velocity curves at atrial contractionJournal of the American Society of Echocardiography, 1997